These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6767486)

  • 1. Trichloroethylene: its interaction with hepatic microsomal cytochrome P-450 in vitro.
    Costa AK; Katz ID; Ivanetich KM
    Biochem Pharmacol; 1980 Feb; 29(3):433-9. PubMed ID: 6767486
    [No Abstract]   [Full Text] [Related]  

  • 2. Pyridine nucleotide cofactor requirements of indicine N-oxide reduction by hepatic microsomal cytochrome P-450.
    Powis G; Wincentsen L
    Biochem Pharmacol; 1980 Feb; 29(3):347-51. PubMed ID: 6767485
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of oxygenated cytochrome P-450 and of cytochrome b5 in hepatic microsomal drug oxidations.
    Baron J; Hildebrandt AG; Peterson JA; Estabrook RW
    Drug Metab Dispos; 1973; 1(1):129-38. PubMed ID: 4149374
    [No Abstract]   [Full Text] [Related]  

  • 4. Tetrachloroethylene metabolism by the hepatic microsomal cytochrome P-450 system.
    Costa AK; Ivanetich KM
    Biochem Pharmacol; 1980 Oct; 29(20):2863-9. PubMed ID: 7437086
    [No Abstract]   [Full Text] [Related]  

  • 5. Pyridine nucleotide involvement in rat hepatic microsomal drug metabolism--II. Evidence for a co-operative interaction between NADPH and NADH.
    Gourlay GK; Stock BH
    Biochem Pharmacol; 1978 Mar; 27(6):969-78. PubMed ID: 26355
    [No Abstract]   [Full Text] [Related]  

  • 6. Enflurane and methoxyflurane. Their interaction with hepatic cytochrome P-450 in vitro.
    Ivanetich KM; Lucas SA; Marsh JA
    Biochem Pharmacol; 1979 Mar; 28(6):785-92. PubMed ID: 36901
    [No Abstract]   [Full Text] [Related]  

  • 7. Cytochrome P450-related differences between rats and mice in the metabolism of benzene, toluene and trichloroethylene in liver microsomes.
    Nakajima T; Wang RS; Elovaara E; Park SS; Gelboin HV; Vainio H
    Biochem Pharmacol; 1993 Mar; 45(5):1079-85. PubMed ID: 8461037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyridine nucleotide involvement in rat hepatic microsomal drug metabolism--III. The influence of the 1,4,5,6-tetrahydronicotinamide analogue of NADP on the NADPH kinetics of aminopyrine-N-demethylation.
    Gourlay GK; Stock BH
    Biochem Pharmacol; 1978 Mar; 27(6):979-83. PubMed ID: 26356
    [No Abstract]   [Full Text] [Related]  

  • 9. The interaction of hepatic microsomal cytochrome P-450 with fluroxene (2,2,2-trifluoroethyl vinyl ether) in vitro.
    Ivanetich KM; Bradshaw JJ; Marsh JA; Kaminsky LS
    Biochem Pharmacol; 1976 Apr; 25(7):779-84. PubMed ID: 7271
    [No Abstract]   [Full Text] [Related]  

  • 10. Mechanism of reduction of nitrofurantoin on liver microsomes.
    Leskovac V; Popović M
    Pharmacol Res Commun; 1980 Jan; 12(1):13-27. PubMed ID: 7384160
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of NADH in uncoupled microsomal monoxygenations.
    Staudt H; Lichtenberger F; Ullrich V
    Eur J Biochem; 1974 Jul; 46(1):99-106. PubMed ID: 4153145
    [No Abstract]   [Full Text] [Related]  

  • 12. Role of cytochrome b5 in the NADH synergism of NADPH-dependent reactions of the cytochrome P-450 monooxygenase system of hepatic microsomes.
    Mannerign GJ
    Adv Exp Med Biol; 1975; 58(00):405-34. PubMed ID: 239543
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunochemical study on the route of electron transfer from NADH and NADPH to cytochrome P-450 of liver microsomes.
    Noshiro M; Harada N; Omura T
    J Biochem; 1980 Nov; 88(5):1521-35. PubMed ID: 7462192
    [No Abstract]   [Full Text] [Related]  

  • 14. Alteration of hepatic microsomal enzymes by griseofulvin treatment of mice.
    Denk H; Eckerstorfer R; Talcott RE; Schenkman JB
    Biochem Pharmacol; 1977 Jun; 26(12):1125-30. PubMed ID: 19022
    [No Abstract]   [Full Text] [Related]  

  • 15. Vinylidene chloride: its metabolism by hepatic microsomal cytochrome P-450 in vitro.
    Costa AK; Ivanetich KM
    Biochem Pharmacol; 1982 Jun; 31(11):2083-92. PubMed ID: 7115426
    [No Abstract]   [Full Text] [Related]  

  • 16. Chloroethanes : their metabolism by hepatic cytochrome P-450 in vitro.
    Ivanetich KM; Van den Honert LH
    Carcinogenesis; 1981; 2(8):697-702. PubMed ID: 7285278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced diphosphopyridine nucleotide synergism of the reduced triphosphopyridine nucleotide-dependent mixed-function oxidase system of hepatic microsomes. II. Role of the type I drug-binding site of cytochrome P-450.
    Correia MA; Mannering GJ
    Mol Pharmacol; 1973 Jul; 9(4):470-85. PubMed ID: 4146890
    [No Abstract]   [Full Text] [Related]  

  • 18. Reduced nicotinamide adenine dinucleotide-dependent reduction of tertiary amine N-oxide by liver microsomal cytochrome P-450.
    Sugiura M; Iwasaki K; Kato R
    Biochem Pharmacol; 1977 Mar; 26(6):489-95. PubMed ID: 192244
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition of NADPH oxidation and related drug oxidation in liver microsomes by zinc.
    Chvapil M; Ludwig JC; Sipes IG; Misiorowski RL
    Biochem Pharmacol; 1976 Aug; 25(15):1787-91. PubMed ID: 8050
    [No Abstract]   [Full Text] [Related]  

  • 20. Suicidal inactivation of hepatic cytochrome P-450 in vitro by some aliphatic olefins.
    Testai E; Citti L; Gervasi P; Turchi G
    Biochem Biophys Res Commun; 1982 Jul; 107(2):633-41. PubMed ID: 7126232
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.